Many people find that weight management program success improves with accurate hormone testing
Studies show that people taking GLP-1 drugs can lose up to 20 percent of their total body weight
It's essential to follow any aftercare instructions provided by the healthcare provider, such as staying hydrated and avoiding direct sunlight to maximize the benefits of the treatment
Most clients describe only mild, brief discomfort at the injection site
FAQs About Weight Loss with Semaglutide and Tirzepatide Tirzepatide and semaglutide is a dual-action medication that mimics natural hormones (GLP-1 and GIP) involved in appetite regulation and metabolism

Whilst occasional hot flushes may not require immediate medical attention, certain situations warrant prompt consultation with your GP or diabetes care team: Seek medical advice if you experience: Severe or persistent hot flushes that significantly interfere with daily activities, work, or sleep quality Hot flushes accompanied by other concerning symptoms such as chest pain, palpitations, severe headache, visual disturbances, or difficulty breathing Signs of hypoglycaemia including trembling, confusion, excessive sweating, dizziness, or feeling faintcheck your blood glucose immediately if possible Symptoms of dehydration such as dark urine, extreme thirst, or reduced urination, particularly if you're also experiencing nausea or vomiting Unexplained fever or hot flushes accompanied by chills, which could indicate infection New or worsening symptoms after starting Ozempic or increasing the dose Contact your healthcare provider for routine review if: Hot flushes persist beyond the initial adjustment period (typically 48 weeks) You're uncertain whether symptoms are related to Ozempic, menopause, or another condition You're considering stopping or changing your medication due to side effects You require guidance on managing symptoms or adjusting your diabetes management plan Seek emergency medical attention (call 999 or attend A&E) if you experience: Severe allergic reaction symptoms including facial swelling, difficulty breathing, or widespread rash Severe, persistent abdominal pain, with or without vomiting, which could indicate pancreatitis (a rare but serious side effect of GLP-1 agonists)
